The Cedars-Sinai Virtual Tumor Board Series: Chronic Myelogenous Leukemia

Title:

The Cedars-Sinai Virtual Tumor Board Series: Chronic Myelogenous Leukemia
Topic: Oncology/ Hematology
Relevant Terms: Chronic Myelogenous Leukemia
Primary Audience: Practicing Medical Oncologists; Hematology-Oncologists; Surgical Oncologists; Radiation Oncologists; Pathologists; Oncology Advanced Practice Nurses and Nurse Practitioners; and Oncology Physician Assistants
Launch Date: 18-Dec-12
Credits: 1 AMA PRA Category 1 Credit™
Expiration Date: 17-Dec-13
Patients Seen:  Mr Tate Mrs Cooper
Curriculum Name: Chronic Myelogenous Leukemia

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Implement evidence-based therapeutic strategies in the frontline and second-line treatment of patients with chronic-phase CML
  2. Review the use of hematologic, cytogenetic, and molecular responses to monitor patients with chronic-phase CML receiving tyrosine kinase inhibitor (TKI) therapy, and analyze strategies for overcoming resistance to TKIs in the management of patients with chronic-phase CML
  3. Evaluate how BCR-ABL mutations may influence the selection of tyrosine kinase inhibitors for the treatment of chronic-phase CML  
  4. Assess data on investigational agents being studied for the treatment of chronic-phase CML 

    Faculty

    Michael Lill, MD
    Professor of Medicine
    Medical Director, Blood and Marrow Transplant Program
    Samuel Oschin Comprehensive Cancer Institute
    Cedars-Sinai Medical Center
    Los Angeles, CA     Solomon Hamburg, MD
    Division of Hematology/Oncology
    Tower Hematology Oncology
    Cedars-Sinai Medical Center
    Clinical Professor of Medicine
    University of California, Los Angeles
    Los Angeles, CA     Stephen Lim, MD
    Associate Professor of Medicine
    Associate Director, Blood and Marrow Transplant Program
    Samuel Oschin Comprehensive Cancer Institute
    Cedars-Sinai Medical Center
    Los Angeles, CA
    Sponsored by
    Cedars-Sinai Medical Center and Educational Concepts Group, LLC
     
     
    Supported by an educational grant from Novartis. 
     
     
    Program Overview
    The VTB format offers learners in-depth comprehensive presentations and faculty discussions that address the identified educational needs in CML. This VTB activity will be led by a CML expert and will include active participation of multiple faculty members who will present data as well as provide practical commentary on a number of clinical management issues for patients with CML. 
     
    Target Audience
    Practicing Medical Oncologists, Hematology-Oncologists, Surgical Oncologists, Radiation Oncologists, Pathologists, Oncology Advanced Practice Nurses and Nurse Practitioners, and Oncology Physician Assistants
     
    Accreditation Statement
    Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
     
    Credit Designation
    Cedars-Sinai Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Disclosure Policy Statement
    It is the policy of Cedars-Sinai Medical Center to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Cedars-Sinai Medical Center assesses conflict of interest with its faculty, planners, and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter's content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.
     
    While Cedars-Sinai Medical Center endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.
     
    When asked to report relevant financial relationships with commercial interests, faculty reported the following:
     
    Solomon Hamburg, MD: No relevant financial relationships to disclose

    Michael Lill, MD: No relevant financial relationships to disclose

    Stephen Lim, MD: No relevant financial relationships to disclose
     
    The materials for this activity were peer reviewed and the reviewer had no relevant financial relationships to report.
     
    Instructions for Participating in This Activity and Obtaining CME Credit
    There are no fees for participating in and receiving CME credit for this online educational activity.
     
    How To Receive Credit
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA Category 1 Credit™. Statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
     
    COURSE FORMAT: Internet CME Activity
    COURSE VIEWING REQUIREMENTS
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac
     
    Release Date: December 18, 2012
    Expiration Date: December 17, 2013
    Estimated Time To Complete: 60 minutes
     
    Cedars-Sinai Medical Center Privacy Policy
    http://www.cedars-sinai.edu/5237.html
     
    Cedars-Sinai Medical Center Terms and Conditions
    http://www.cedars-sinai.edu/5238.html
     
    ©2012 Cedars-Sinai Medical Center and Educational Concepts Group, LLC